Muhammad Rizwan

1.2k total citations · 1 hit paper
12 papers, 938 citations indexed

About

Muhammad Rizwan is a scholar working on Psychiatry and Mental health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Muhammad Rizwan has authored 12 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Muhammad Rizwan's work include Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers), Genetic Neurodegenerative Diseases (2 papers) and T-cell and Retrovirus Studies (1 paper). Muhammad Rizwan is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers), Genetic Neurodegenerative Diseases (2 papers) and T-cell and Retrovirus Studies (1 paper). Muhammad Rizwan collaborates with scholars based in Sweden, Pakistan and Jordan. Muhammad Rizwan's co-authors include Mohammad S. Mubarak, Abdur Rauf, Mohammad Ali Shariati, Muhammad Nadeem, Muhammad Imran, Ali Imran, Tareq Abu‐Izneid, Muhammad Atif, İlkay Erdoğan Orhan and Tanweer Aslam Gondal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Journal of General Virology.

In The Last Decade

Muhammad Rizwan

12 papers receiving 925 citations

Hit Papers

Luteolin, a flavonoid, as an anticancer agent: A review 2019 2026 2021 2023 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Luteolin, a flavonoid, as an anticancer agent: A review
    2019 713 citations Muhammad Imran, Abdur Rauf et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhammad Rizwan Sweden 9 366 125 114 110 108 12 938
Gomaa Mostafa‐Hedeab Egypt 22 431 1.2× 37 0.3× 138 1.2× 119 1.1× 68 0.6× 68 1.3k
Narayanasamy Angayarkanni India 21 369 1.0× 43 0.3× 91 0.8× 105 1.0× 58 0.5× 64 1.3k
Ilaria Tresoldi Italy 17 445 1.2× 38 0.3× 113 1.0× 112 1.0× 201 1.9× 25 1.1k
Sümeyya Akyol Türkiye 19 425 1.2× 30 0.2× 96 0.8× 111 1.0× 91 0.8× 65 1.3k
Manuel Ibarra Uruguay 15 239 0.7× 101 0.8× 50 0.4× 77 0.7× 165 1.5× 58 968
Jing Yang China 21 650 1.8× 56 0.4× 161 1.4× 262 2.4× 46 0.4× 123 1.4k
Haiyan Xing China 17 338 0.9× 79 0.6× 53 0.5× 70 0.6× 50 0.5× 52 796
Thacyana T. Carvalho Brazil 18 447 1.2× 39 0.3× 180 1.6× 161 1.5× 123 1.1× 32 1.4k

Countries citing papers authored by Muhammad Rizwan

Since Specialization
Citations

This map shows the geographic impact of Muhammad Rizwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Rizwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Rizwan more than expected).

Fields of papers citing papers by Muhammad Rizwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Rizwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Rizwan. The network helps show where Muhammad Rizwan may publish in the future.

Co-authorship network of co-authors of Muhammad Rizwan

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Rizwan. A scholar is included among the top collaborators of Muhammad Rizwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Rizwan. Muhammad Rizwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rizwan, Muhammad, et al.. (2025). Can WGX-50 be a potential therapy to treat tumor by inhibiting mitochondrial reactive oxidative species?. Medical Hypotheses. 196. 111583–111583. 1 indexed citations
2.
Sayyab, Shumaila, Eirini Apostolou, Muhammad Rizwan, et al.. (2022). Epigenetic rewiring of pathways related to odour perception in immune cells exposed to SARS-CoV-2in vivoandin vitro. Epigenetics. 17(13). 1875–1891. 7 indexed citations
3.
Apostolou, Eirini, Muhammad Rizwan, Petros Moustardas, et al.. (2022). Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome. Frontiers in Immunology. 13. 949787–949787. 34 indexed citations
4.
Palmer, Jeremy M., Eirini Apostolou, Carl‐Gerhard Gottfries, et al.. (2020). Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies. Frontiers in Medicine. 7. 108–108. 11 indexed citations
5.
Blomberg, Jonas, Muhammad Rizwan, Amal Elfaitouri, et al.. (2019). Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Frontiers in Immunology. 10. 1946–1946. 21 indexed citations
6.
Imran, Muhammad, Abdur Rauf, Tareq Abu‐Izneid, et al.. (2019). Luteolin, a flavonoid, as an anticancer agent: A review. Biomedicine & Pharmacotherapy. 112. 108612–108612. 713 indexed citations breakdown →
7.
Blomberg, Jonas, Carl‐Gerhard Gottfries, Amal Elfaitouri, Muhammad Rizwan, & Anders Rosén. (2018). Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model. Frontiers in Immunology. 9. 229–229. 94 indexed citations
8.
Khan, Sajad, Abdur Rauf, Muhammad Rizwan, et al.. (2017). Comprehensive Review on Ebola (EBOV) Virus: Future Prospects. Infectious Disorders - Drug Targets. 18(2). 96–104. 11 indexed citations
9.
Ahmad, Bashir, Muhammad Rizwan, Abdur Rauf, et al.. (2017). Isolation of Chlorogenic Acid from Soil Borne Fungi Screlotium rolfsii, their Reversal of Multidrug Resistance and Anti-proliferative in Mouse Lymphoma Cells. Medicinal Chemistry. 13(8). 721–726. 10 indexed citations
10.
Rizwan, Muhammad, et al.. (2016). Serology in the Digital Age: Using Long Synthetic Peptides Created from Nucleic Acid Sequences as Antigens in Microarrays. SHILAP Revista de lepidopterología. 5(3). 22–22. 7 indexed citations
11.
Rizwan, Muhammad, Saqib Ali, Saira Shahzadi, et al.. (2013). Synthesis, characterization, HOMO–LUMO study, and antimicrobial activity of organotin(IV) complexes of 4-piperidine carboxamide and its Schiff base. Journal of Coordination Chemistry. 67(2). 341–351. 17 indexed citations
12.
Wensman, Jonas Johansson, Muhammad Munir, Katarina Hörnaeus, et al.. (2012). The X proteins of bornaviruses interfere with type I interferon signalling. Journal of General Virology. 94(2). 263–269. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gomaa Mostafa‐Hedeab Breakdown of academic impact, for papers by Narayanasamy Angayarkanni Breakdown of academic impact, for papers by Ilaria Tresoldi Breakdown of academic impact, for papers by Sümeyya Akyol Breakdown of academic impact, for papers by Manuel Ibarra Breakdown of academic impact, for papers by Jing Yang Breakdown of academic impact, for papers by Haiyan Xing Breakdown of academic impact, for papers by Thacyana T. Carvalho
Rankless by CCL
2026